Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ALBI Grade (Liver)ASTCT GradingATA Thyroid RiskBCLC 2022 Staging (HCC)BSA (Mosteller)CLL-IPICML ELTS ScoreCNS-IPICTCAE v5.0Calvert FormulaDIPSS-Plus (Myelofibrosis)Deauville ScoreEAU NMIBC RiskECOG Performance StatusELN 2022 Risk (AML)ELN CML MilestonesFIGO 2021 (Ovarian)FIGO 2023 (Endometrial)FLIPI-2Fleischner 2017 GuidelinesFong Clinical Risk ScoreHCT-CI (Sorror Score)HPV/p16 OropharynxIGCCCG Risk (Testicular)IMDC (Heng) CriteriaIMWG Myeloma FrailtyIPSS-M (Molecular MDS)ISUP Grade GroupsKarnofsky Status (KPS)Khorana ScoreLugano ClassificationLung-RADS v2022MIPI-b (Biological)MRD Assessment FrameworkMSI/MMR InterpretationMayo 20/2/20 (SMM)NCCN Prostate RiskNCCN-IPI (DLBCL)NSCLC GPAOncotype DX RecurrenceOpioid EquianalgesicPD-L1 TPS InterpretationPERCIST 2.0PREDICT v3.0Platinum-Free IntervalR2-ISS (Revised 2)RANO 2.0RCB (Residual Cancer Burden)RECIST 1.1ROMA ScoreSAVER ScoreSINS ScoreSLiM-CRAB CriteriaSedlis/Peters CriteriaTNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AMLZ0011 EligibilityiRECISTiwCLL 2018 ResponsemRECIST (HCC)mRENAL ScoremrTRG (Rectal MRI)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

Intensive Care MedicineJun 8, 2026
Is acute respiratory distress syndrome a preventable disease?

Clinical Context

We think this has broad domain relevance to CML ELTS Score.

Intensive Care MedicineJun 8, 2026
Patient blood management in general intensive care patients

Clinical Context

We think this has broad domain relevance to CML ELTS Score.

Cancer MedicineJun 5, 2026
Acalabrutinib Versus Venetoclax Plus Obinutuzumab in Treatment‐Naive Chronic Lymphocytic Leukemia: A Real‐World Propensity Score‐Matched Study

Clinical Context

We think this has broad domain relevance to CML ELTS Score.

CML ELTS Score

ELTS SCOREEUTOS Long-Term Survival for CML

Clinical Parameters

years
cm BCM

cm below costal margin

%
x10⁹/L

Awaiting Lab Values

The ELTS score is the preferred tool for CML risk assessment in the modern TKI era.

Risk Tiers

  • Low Risk: Excellent long-term OS
  • Intermediate: Standard CML risk
  • High Risk: Higher leukemia mortality
Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Clinical Use

Baseline risk assessment of patients in Chronic Phase CML.
Estimating the probability of CML-related death.
Aiding the selection of first-line TKI (e.g., deciding between Imatinib or more potent 2nd generation TKIs like Dasatinib/Nilotinib).

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the ELN CML Milestones, Who Icc 2022 Aml or the CLL-IPI to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Oncology Tools

ELN CML Milestones
CLL-IPI
ISUP Grade Groups
BCLC 2022 Staging
R2-ISS
MSI/MMR Interpretation
Calvert Formula
NCCN Prostate Risk
IPSS-M
NSCLC GPA
Oncology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.